ATRA Press Release: $12M Revenue, $0.05 EPS, +15% YoY, $200M Deal Size
Atara Biotherapeutics, Inc · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $10.28
-16% in 1d after detection
Post-detection moves
1h
—
1d
-16%
3d
-1.2%
7d
-7.9%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS